StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the medical research company’s stock.
Check-Cap Stock Performance
NASDAQ:CHEK opened at $1.15 on Thursday. The company has a market cap of $6.73 million, a price-to-earnings ratio of -0.38 and a beta of 0.36. The stock’s fifty day moving average price is $1.62 and its two-hundred day moving average price is $1.95. Check-Cap has a 52-week low of $1.12 and a 52-week high of $3.94.
Check-Cap Company Profile
See Also
- Five stocks we like better than Check-Cap
- Which Wall Street Analysts are the Most Accurate?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Most active stocks: Dollar volume vs share volume
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.